Mimedx (MDXG) Assets (2010 - 2026)
Mimedx (MDXG) posted Assets of $281.0 million for Q2 2026, down 8.97% sequentially from $308.7 million in Q1 2026, and down 3.47% YoY from $291.1 million in Q2 2025.
Mimedx (MDXG) Assets (2010 - 2026) Analysis & Trends
Mimedx has reported Assets for 17 years, with the latest figure at $281.0 million in Q2 2026.
- Quarterly Assets fell 3.47% year-over-year to $281.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $281.0 million (down 3.47% YoY) and the FY2025 annual result came in at $342.7 million, up 29.83% from the prior year.
- Assets fell to $281.0 million in Q2 2026 per MDXG's latest filing, from $308.7 million in the prior quarter.
- Over five years, Assets peaked at $342.7 million in Q4 2025 and troughed at $168.2 million in Q1 2023.
- A 5-year average of $235.1 million and a median of $234.6 million in 2023 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2023: Assets declined 9.87% in 2022, then soared 39.44% in 2023.
- Over 5 years, Assets stood at $171.4 million in 2022, then soared by 39.44% to $239.0 million in 2023, then climbed by 10.4% to $263.9 million in 2024, then rose by 29.83% to $342.7 million in 2025, then fell by 17.99% to $281.0 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $281.0 million, $308.7 million, and $342.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Mimedx | 622.24 Mn | 486.40 Mn | 44.38 Mn | 281.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 281.00 Mn |
| Mar 31, 2026 | 308.68 Mn |
| Dec 31, 2025 | 342.65 Mn |
| Sep 30, 2025 | 318.99 Mn |
| Jun 30, 2025 | 291.11 Mn |
| Mar 31, 2025 | 270.42 Mn |
| Dec 31, 2024 | 263.92 Mn |
| Sep 30, 2024 | 243.89 Mn |
| Jun 30, 2024 | 230.18 Mn |
| Mar 31, 2024 | 221.68 Mn |
| Dec 31, 2023 | 239.05 Mn |
| Sep 30, 2023 | 189.02 Mn |
| Jun 30, 2023 | 176.38 Mn |
| Mar 31, 2023 | 168.16 Mn |
| Dec 31, 2022 | 171.43 Mn |
| Sep 30, 2022 | 172.80 Mn |
| Jun 30, 2022 | 168.67 Mn |
| Mar 31, 2022 | 174.44 Mn |
| Dec 31, 2021 | 187.93 Mn |
| Sep 30, 2021 | 180.52 Mn |